Advertisement
Screener

MELINTA THERAPEUTICS, INC. /NEW/ Research and Development Expense

MELINTA THERAPEUTICS, INC. /NEW/ Research and Development Expense

MELINTA THERAPEUTICS, INC. /NEW/ reported Research and Development Expense of $4.70 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2019-11-12

  • MELINTA THERAPEUTICS, INC. /NEW/ research and development expense for the quarter ending 2019-09-30 was $4.70M, a 64.06% decline year-over-year.
  • MELINTA THERAPEUTICS, INC. /NEW/ research and development expense for the quarter ending 2019-06-30 was $3.53M, a 77.70% decline year-over-year.
  • MELINTA THERAPEUTICS, INC. /NEW/ research and development expense for the quarter ending 2019-03-31 was $5.36M, a 66.74% decline year-over-year.
  • MELINTA THERAPEUTICS, INC. /NEW/ research and development expense for the quarter ending 2018-12-31 was $10.40M, a 10.32% decline year-over-year.
  • MELINTA THERAPEUTICS, INC. /NEW/ research and development expense for fiscal 2018 was $55.41M, a 11.99% increase from fiscal 2017.
  • MELINTA THERAPEUTICS, INC. /NEW/ research and development expense for fiscal 2017 was $49.48M, a 0.63% decline from fiscal 2016.
  • MELINTA THERAPEUTICS, INC. /NEW/ research and development expense for fiscal 2016 was $49.79M, a 20.70% decline from fiscal 2015.
  • MELINTA THERAPEUTICS, INC. /NEW/ research and development expense for fiscal 2015 was $62.79M, a 0.40% increase from fiscal 2014.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 6 month as first filedResearch and Development Expense 9 monthResearch and Development Expense 9 month as first filedResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filedResearch and Development Expense 76 monthResearch and Development Expense 79 monthResearch and Development Expense 82 monthResearch and Development Expense 85 monthResearch and Development Expense 88 monthResearch and Development Expense 91 monthResearch and Development Expense 94 month
2019-09-30$4.70M
10-Q · filed 2019-11-12
$8.22M
derived: sum of 2 quarters · filed 2019-11-12
$13.59M
10-Q · filed 2019-11-12
$23.99M
derived: sum of 4 quarters · filed 2019-11-12
2019-06-30$3.53M
10-Q · filed 2019-08-09
$8.89M
10-Q · filed 2019-08-09
$19.29M
derived: sum of 3 quarters · filed 2019-08-09
$32.36M
derived: sum of 4 quarters · filed 2019-11-12
2019-03-31$5.36M
10-Q · filed 2019-05-10
$15.77M
derived: sum of 2 quarters · filed 2019-05-10
$28.83M
derived: sum of 3 quarters · filed 2019-11-12
$44.64M
derived: sum of 4 quarters · filed 2019-11-12
2018-12-31$10.40M
10-K · filed 2019-03-14
$23.47M
derived: sum of 2 quarters · filed 2019-11-12
$39.28M
derived: sum of 3 quarters · filed 2019-11-12
$55.41M
10-K · filed 2019-03-14
2018-09-30$13.06M
10-Q · filed 2019-11-12
$28.88M
derived: sum of 2 quarters · filed 2019-11-12
$45.01M
10-Q · filed 2019-11-12
$56.61M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$15.81M
10-Q · filed 2019-08-09
$31.94M
10-Q · filed 2019-08-09
$43.54M
derived: sum of 3 quarters · filed 2019-08-09
$54.42M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31$16.13M
10-Q · filed 2019-05-10
$27.73M
derived: sum of 2 quarters · filed 2019-05-10
$38.61M
derived: sum of 3 quarters · filed 2019-05-10
$52.69M
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31$11.60M
10-K · filed 2019-03-14
$22.48M
derived: sum of 2 quarters · filed 2019-03-14
$36.56M
derived: sum of 3 quarters · filed 2019-03-14
$49.48M
10-K · filed 2019-03-14
2017-09-30$10.88M
10-K · filed 2019-03-14
$4.38M
10-Q · filed 2017-11-02
$24.96M
derived: sum of 2 quarters · filed 2019-03-14
$37.88M
10-Q · filed 2018-11-07
$28.34M
10-Q · filed 2017-11-02
$54.18M
derived: sum of 4 quarters · filed 2019-03-14
2017-06-30$14.07M
10-K · filed 2019-03-14
$8.54M
10-Q · filed 2017-08-09
$26.99M
10-Q · filed 2018-08-09
$23.95M
10-Q · filed 2017-08-09
$43.29M
derived: sum of 3 quarters · filed 2019-03-14
$53.18M
derived: sum of 4 quarters · filed 2019-03-14
2017-03-31$12.92M
10-K · filed 2019-03-14
$15.41M
10-Q · filed 2017-04-28
$29.22M
derived: sum of 2 quarters · filed 2019-03-14
$39.11M
derived: sum of 3 quarters · filed 2019-03-14
$48.95M
derived: sum of 4 quarters · filed 2019-03-14
2016-12-31$16.30M
10-K · filed 2018-03-16
$21.04M
10-K · filed 2017-02-28
$26.19M
derived: sum of 2 quarters · filed 2018-03-16
$36.04M
derived: sum of 3 quarters · filed 2018-03-16
$49.79M
10-K · filed 2019-03-14
$81.69M
10-K · filed 2017-02-28
2016-09-30$9.89M
10-K · filed 2018-03-16
$21.10M
10-Q · filed 2016-10-27
$19.73M
derived: sum of 2 quarters · filed 2018-03-16
$60.64M
10-Q · filed 2017-11-02
$53.51M
derived: sum of 4 quarters · filed 2018-03-16
2016-06-30$9.85M
10-K · filed 2018-03-16
$16.02M
10-Q · filed 2016-08-01
$39.55M
10-Q · filed 2017-08-09
$43.62M
derived: sum of 3 quarters · filed 2018-03-16
$67.16M
derived: sum of 4 quarters · filed 2018-03-16
2016-03-31$13.75M
10-K · filed 2018-03-16
$23.53M
10-Q · filed 2016-05-02
$33.77M
derived: sum of 2 quarters · filed 2018-03-16
$57.31M
derived: sum of 3 quarters · filed 2018-03-16
$80.99M
derived: sum of 4 quarters · filed 2018-03-16
2015-12-31$20.02M
10-K · filed 2017-02-28
$43.56M
derived: sum of 2 quarters · filed 2017-02-28
$67.23M
derived: sum of 3 quarters · filed 2017-02-28
$62.79M
10-K · filed 2018-03-16
$93.35M
10-K · filed 2016-02-25
2015-09-30$23.54M
10-K · filed 2017-02-28
$23.54M
10-Q · filed 2015-10-22
$47.22M
derived: sum of 2 quarters · filed 2017-02-28
$73.33M
10-Q · filed 2016-10-27
$73.33M
10-Q · filed 2015-10-22
$88.64M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$23.68M
10-K · filed 2017-02-28
$23.68M
10-Q · filed 2015-07-29
$49.79M
10-Q · filed 2016-08-01
$49.79M
10-Q · filed 2015-07-29
$65.10M
derived: sum of 3 quarters · filed 2017-02-28
$80.75M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31$26.12M
10-K · filed 2017-02-28
$26.12M
10-Q · filed 2015-04-30
$41.42M
derived: sum of 2 quarters · filed 2017-02-28
$57.08M
derived: sum of 3 quarters · filed 2017-02-28
$72.27M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$15.30M
10-K · filed 2016-02-25
$30.96M
derived: sum of 2 quarters · filed 2016-02-25
$46.16M
derived: sum of 3 quarters · filed 2016-02-25
$62.54M
10-K · filed 2017-02-28
$62.54M
10-K · filed 2015-02-26
2014-09-30$15.65M
10-K · filed 2016-02-25
$15.65M
10-Q · filed 2014-10-29
$30.85M
derived: sum of 2 quarters · filed 2016-02-25
$47.23M
10-Q · filed 2015-10-22
$62.92M
derived: sum of 4 quarters · filed 2016-02-25
2014-06-30$15.20M
10-K · filed 2016-02-25
$15.20M
10-Q · filed 2014-07-29
$31.58M
10-Q · filed 2015-07-29
$47.26M
derived: sum of 3 quarters · filed 2016-02-25
$59.18M
derived: sum of 4 quarters · filed 2016-02-25
2014-03-31$16.38M
10-K · filed 2016-02-25
$16.38M
10-Q · filed 2014-04-29
$32.07M
derived: sum of 2 quarters · filed 2016-02-25
$43.98M
derived: sum of 3 quarters · filed 2016-02-25
$50.31M
derived: sum of 4 quarters · filed 2016-02-25
2013-12-31$15.68M
10-K · filed 2015-02-26
$27.60M
derived: sum of 2 quarters · filed 2015-02-26
$33.93M
derived: sum of 3 quarters · filed 2015-02-26
$41.30M
10-K · filed 2016-02-25
2013-09-30$11.92M
10-K · filed 2015-02-26
$11.92M
10-Q · filed 2013-10-29
$18.25M
derived: sum of 2 quarters · filed 2015-02-26
$25.62M
10-Q · filed 2014-10-29
$30.03M
derived: sum of 4 quarters · filed 2015-02-26
$109.34M
10-Q · filed 2013-10-29
2013-06-30$6.33M
10-K · filed 2015-02-26
$6.33M
10-Q · filed 2013-07-31
$13.70M
10-Q · filed 2014-07-29
$18.11M
derived: sum of 3 quarters · filed 2015-02-26
$21.27M
derived: sum of 4 quarters · filed 2015-02-26
$97.43M
10-Q · filed 2013-07-31
2013-03-31$7.37M
10-K · filed 2015-02-26
$7.37M
10-Q · filed 2013-04-25
$11.78M
derived: sum of 2 quarters · filed 2015-02-26
$14.94M
derived: sum of 3 quarters · filed 2015-02-26
$22.36M
derived: sum of 4 quarters · filed 2015-02-26
$91.10M
10-Q · filed 2013-04-25
2012-12-31$4.41M
10-K · filed 2014-02-28
$7.57M
derived: sum of 2 quarters · filed 2014-02-28
$14.99M
derived: sum of 3 quarters · filed 2014-02-28
$16.87M
10-K · filed 2015-02-26
$83.73M
10-K · filed 2013-03-07
2012-09-30$3.16M
10-K · filed 2014-02-28
$3.16M
10-Q · filed 2012-11-08
$10.58M
derived: sum of 2 quarters · filed 2014-02-28
$12.46M
10-Q · filed 2013-10-29
$13.91M
derived: sum of 4 quarters · filed 2014-02-28
$79.31M
10-Q · filed 2012-11-08
2012-06-30$7.42M
10-K · filed 2014-02-28
$7.42M
10-Q · filed 2012-08-08
$9.30M
10-Q · filed 2013-07-31
$10.76M
derived: sum of 3 quarters · filed 2014-02-28
$17.42M
derived: sum of 4 quarters · filed 2014-02-28
$76.16M
10-Q · filed 2012-08-08
2012-03-31$1.88M
10-K · filed 2014-02-28
$1.88M
10-Q · filed 2012-05-10
$3.33M
derived: sum of 2 quarters · filed 2014-02-28
$9.99M
derived: sum of 3 quarters · filed 2014-02-28
$14.36M
derived: sum of 4 quarters · filed 2014-02-28
$68.73M
10-Q · filed 2012-05-10
2011-12-31$1.46M
10-K · filed 2013-03-07
$8.12M
derived: sum of 2 quarters · filed 2013-03-07
$12.48M
derived: sum of 3 quarters · filed 2013-03-07
$16.87M
10-K · filed 2014-02-28
2011-09-30$6.66M
10-K · filed 2013-03-07
$6.66M
10-Q · filed 2012-11-08
$11.02M
derived: sum of 2 quarters · filed 2013-03-07
$15.41M
10-Q · filed 2012-11-08
2011-06-30$4.36M
10-K · filed 2013-03-07
$4.36M
10-Q · filed 2012-08-08
$8.75M
10-Q · filed 2012-08-08
2011-03-31$4.39M
10-K · filed 2013-03-07
$4.39M
10-Q · filed 2012-05-10
2010-12-31$15.47M
10-K · filed 2013-03-07